List view / Grid view
29 July 2013 | By Merck
Merck and the ADAP Crisis Task Force (ACTF) announced that the company will extend its commitment to support state AIDS Drug Assistance Programs (ADAPs)...
29 July 2013 | By Pfizer
Pfizer announces reduced advance market commitment price with a further reduction beginning in 2014...
29 July 2013 | By Abbott
As U.S. healthcare providers navigate a changing healthcare climate, clinical laboratories are playing an increasingly important role in helping them prevent medical errors, lower readmission rates, and improve patient care...
29 July 2013 | By GlaxoSmithKline
New extension of Synflorix vaccine supply agreement will help protect an additional 80 million children...
29 July 2013 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and Samsung BioLogics announced the companies have entered into a 10-year agreement...
29 July 2013 | By Perfecseal
Perfecseal introduces a new, high barrier PVC-FREE blister forming web, PerfecForm® SkyBlue™...
29 July 2013 | By
Perfecseal introduces a new high barrier flow wrap specification, PerfecPharm™ P232...
29 July 2013 | By Daiichi Sankyo
Daiichi Sankyo announced that it will expand its Take a New challenge for Drug diScovery Global Program...
26 July 2013 | By Novartis
Novartis announced that the CHMP of the EMA has adopted a positive opinion for the use of Ilaris® (canakinumab)...
26 July 2013 | By Merck
“Nothing is more important to us than the safety of our medicines..."
26 July 2013 | By GlaxoSmithKline
“A sustained virologic response is the goal for treatment of hepatitis C infection..."
26 July 2013 | By Boehringer Ingelheim
"Boehringer Ingelheim welcomes the decision by the CHMP..."
26 July 2013 | By Novartis
Novartis announced that the EMA's CHMP has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®...
26 July 2013 | By Virgo Health
“The number of people at risk from complications associated with type 2 diabetes continues to rise..."
25 July 2013 | By AstraZeneca
The US FDA has acknowledged receipt of the NDA resubmission for investigational drug dapagliflozin for the treatment of adults with type 2 diabetes...
